Skip to main content

Press releases | November 1, 2022

Fried Frank acted as counsel to Goldman Sachs as financial advisor to Abiomed in its $16.6b acquisition by Johnson & Johnson in one of the largest medtech transactions of all time. Johnson & Johnson is the world’s largest, most diversified healthcare products company. Abiomed specializes in heart, lung and kidney support technologies. 

Partner Philip Richter led the team.

 


This communication is for general information only. It is not intended, nor should it be relied upon, as legal advice. In some jurisdictions, this may be considered attorney advertising. Please refer to the firm’s data policy page for further information.